MedTrace Logo

Toradol v. Celecoxib for Postoperative Pain

NCT03331315 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2023-12-07

Study results available
· View outcomes & findings →

Summary

Randomized control trial between ketorolac versus celecoxib for postoperative pain following hysterectomy.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Celecoxib

DRUG

Ketorolac

Sponsors & Collaborators

  • Michael Ulm, MD

    lead OTHER

Principal Investigators

  • Michael A Ulm, MD · University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2016-06-30
Completion
2017-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03331315 on ClinicalTrials.gov